Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
about
How citation distortions create unfounded authority: analysis of a citation networkUpdate in inclusion body myositisIncidence and prevalence of inflammatory myopathies: a systematic reviewTargeting protein homeostasis in sporadic inclusion body myositis.Micropublications: a semantic model for claims, evidence, arguments and annotations in biomedical communicationsImmunotherapies for Immune-Mediated Myopathies: A Current PerspectiveA graph theoretical approach to data fusionA retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.Blood flow restricted resistance training attenuates myostatin gene expression in a patient with inclusion body myositisDeciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stressProteomic study of sporadic inclusion body myositis.Treatment of sporadic inclusion body myositis with bimagrumabAutoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.Immunotherapy of inflammatory myopathies: practical approach and future prospects.Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul/Turkey: a muscle biopsy based survey.Effectiveness and cost-effectiveness of a self-management group program to improve social participation in patients with neuromuscular disease and chronic fatigue: protocol of the Energetic study.Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders.Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositisIn inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized.Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review.Idiopathic inflammatory myopathies: current and future therapeutic options.Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis.Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.Review: An update on inflammatory and autoimmune myopathies.Myosinopathies: pathology and mechanisms.Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study.Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.Transforming growth factor-β signaling is upregulated in sporadic inclusion body myositis.Long-term observational study of sporadic inclusion body myositis.
P2860
Q24260685-57A71E7F-3704-44DD-A74D-EA0BA21FDD3CQ26829906-200D8DA3-701D-4547-A9E7-AE7AC785C119Q26999366-2508A7A3-B4B1-468A-8633-E9602F53D3D8Q27324564-4DB2AC00-BC0C-48F9-A7F4-22CD2AAFD879Q28631063-9DD0B6E6-D856-4173-9C24-7A3E1DCDEBF3Q30699742-F1D544FD-AE49-4409-BF4E-4EE5D2584B78Q31060656-E23D478E-C795-41E7-883A-52BFB09585D9Q33569443-06909804-16EC-4683-9629-05D843C07B1AQ33703048-00169A09-3D6F-41DD-9558-90C51BBAFD41Q33717793-0F70D529-50EA-468D-8724-B191E0814ED0Q33759524-1420D8C3-F679-4E09-88CC-02034CD7AA5BQ34234305-0BC5F6B5-7812-4936-B4D8-4460D49C93CCQ34446951-9D6E6224-6682-435A-AAA1-444B1E789CF7Q34447370-D52E0F83-951E-4F59-A194-C3D4D534AB06Q34627294-A8221CC0-B41B-4EDA-A684-B635711FFA7AQ34675925-EA6A9F37-360E-4BA1-9D18-F04123BF0184Q35060401-845EE86A-BC0C-47F6-9FE5-75301653E825Q35261892-A3676927-4754-463B-81D7-8A04F3ACF25FQ35544490-C0D86D9A-8B97-45D4-A28C-DC42B39F09B2Q35780802-62608083-AEA9-45A8-A290-DF2B33504025Q36424500-9E85AEE9-9C18-4F65-B0A6-F81FA26D95F3Q36575286-AC5780A9-1272-4E7F-95E0-AD9DCEBDB699Q36963892-86CF9E88-A0B8-4603-B669-30D5503B22B8Q37083992-E2000524-D5FD-4C7A-B09C-EE0970ECD55CQ37137973-EFD4232C-64D7-4BEE-A79E-ED7DF2E2C689Q37201405-250C602A-6D21-41A7-A545-73B688D74AE5Q37267141-8A65D772-15E0-4A0C-8F9C-390848C48601Q37329526-C95CD48A-56F4-472A-B644-F78FA01427EBQ37400774-6052930A-53BD-47B0-B747-0630D58FA107Q37418497-74E26200-DCFB-41CB-97FD-5AEEB93F6E6CQ37562794-222EE31C-7C73-4967-A26F-53D49EEFFF7DQ37706412-5361B21E-72A4-4FAD-A755-4A411916ADE8Q37820692-9E9A791B-9039-4C09-A295-F24A09D8B4A1Q38037315-6A3EE2AB-8F54-4308-93C6-FB061221AC05Q38131966-7D86A8B5-089D-4D7F-B2E1-8D0D491EE65FQ38296485-0627BC79-412C-4024-A86B-ECB42F433455Q39021882-DFF2CAE0-D375-4DB4-AB13-97B04E1F91A7Q39382516-34A21AFC-4BF0-4035-A63B-D5CF3C0DB377Q39395489-013BBF6C-ADCC-487E-A1BE-A5344F7E06BAQ39698054-AD4962CC-9E55-44A4-A6DF-DC21A7BAAB73
P2860
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inclusion body myositis: curre ...... ic and therapeutic approaches.
@en
type
label
Inclusion body myositis: curre ...... ic and therapeutic approaches.
@en
prefLabel
Inclusion body myositis: curre ...... ic and therapeutic approaches.
@en
P1433
P1476
Inclusion body myositis: curre ...... ic and therapeutic approaches.
@en
P2093
Frank L Mastaglia
Merrilee Needham
P304
P356
10.1016/S1474-4422(07)70171-0
P577
2007-07-01T00:00:00Z